Letters to the Editor

ONF 2003, 30(3), 361-363. DOI: 10.1188/03.ONF.361-363

Jump to a section


    Bernhardt, B.A., Geller, G., Doksum, T., & Metz, S.A. (2000). Evaluation of nurses and genetic counselors as providers of education about breast cancer susceptibility testing. Oncology Nursing Forum, 27, 33-39.

    Berry, D.A., Parmigiani, G., Sanchez, J., Schildkraut, J., & Winer, E. (1997). Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. Journal of the National Cancer Institute, 89, 227-238.

    Couch, F.J., DeShano, M.L., Blackwood, M.A., Calzone, K., Stopfer, J., Campeau, L., et al. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New England Journal of Medicine, 336, 1409-1415.

    Frank, T.S., Manley, S.A., Olopade, O.I., Cummings, S., Garber, J.E., Bernhardt, B., et al. (1998). Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. Journal of Clinical Oncology, 16, 2417-2425.

    Greco, K. (2002). Genetic counseling and screening. In K. Jennings-Dozier & S.M. Mahon, (Eds.) Cancer prevention, detection, and control: A nursing perspective (pp. 727-766). Pittsburgh, PA: Oncology Nursing Society.

    International Society of Nurses in Genetics & American Nurses Association. (1998). Statement on the scope and standards of genetics clinical nursing practice. Washington, DC: American Nurses Association.

    Oncology Nursing Society. (1998). The role of the oncology nurse in cancer genetic counseling [Position statement]. Oncology Nursing Forum, 25, 463.

    Shattuck-Eidens, D., Oliphant, A., McClure, M., McBride, C., Gupte, J., Rubano, T., et al. (1997). BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA, 278, 1242-1250.

    Vogel, W.H. (2003). The advanced practice nursing role in a high-risk breast cancer clinic. Oncology Nursing Forum, 30, 115-122.

    Wasserman, L.M., Jones, O.W., Trombold, J.S., & Sadler, G.R. (2000). Attitudes of physicians regarding receiving and storing patients' genetic testing results for cancer susceptibility. Journal of Community Health, 25, 305-313.

    Applebaum-Shapiro, S.E., Peters, J.A., O'Connell, J.A., Aston, C.E., & Whitcomb, D.C. (2001). Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis. American Journal of Gastroenterology, 96, 1610-1617.

    Friedrich, M. J. (2002). Preserving privacy, preventing discrimination becomes the province of genetics experts. JAMA, 288, 815-816, 819.

    Lee, S.C., Bernhardt, B.A., & Helzlsouer, K.J. (2002). Utilization of BRCA1/2 genetic testing in the clinical setting: Report from a single institution. Cancer, 94, 1876-1885.

    National Human Genome Research Institute. (2003). Genetic information and health insurance enacted legislation. Retrieved March 12, 2003, from http://www.genome.gov/page.cfm?pageID=10002338

    Peterson, E.A., Milliron, K.J., Lewis, K.E., Goold, S.D., & Merajver, S.D. (2002). Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiology, Biomarkers and Prevention, 11, 79-87.

    U.S. Department of Energy. (2003). Human Genome Project information. Retrieved March 12, 2003, from http://www.ornl.gov/hgmis

    Lang, N.M., & Jennings, B.M. (2002). Nurses and nursing in the health care quality arena. Journal of Professional Issues in Nursing, 18, 60, 112.

    Milio, N. (2002). A new leadership role for nursing in a globalized world. Topics in advanced practice nursing. Retrieved January 28, 2003, from http://www.medscape.com/viewarticle/421474

    Peters, R.M. (2002). Nurse administrators' role in health care policy: Teaching the elephant to dance. Nursing Administration Quarterly, 26, 1-8.